Enovis CORP
Enovis Corporation (NYSE: ENOV) operates as a global medical technology company dedicated to advancing patient mobility and recovery through innovative orthopedic and rehabilitation solutions. The company's website is www.enovis.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Enovis CORP does
In the company’s own words
Enovis Corporation (NYSE: ENOV) operates as a global medical technology company dedicated to advancing patient mobility and recovery through innovative orthopedic and rehabilitation solutions. The company's website is www.enovis.com.
The company operates through two primary reportable segments: Global Orthopedics Group and Global Rehabilitation Group. The Global Orthopedics Group develops and markets orthopedic bracing, supports, and mobility devices, while the Global Rehabilitation Group provides rehabilitation therapy equipment, supplies, and digital health solutions designed to enhance patient outcomes across various care settings.
Enovis serves healthcare providers, patients, and consumers across multiple channels including direct sales, distributors, and retail partnerships. The company maintains a significant international presence with operations spanning North America, Europe, Asia-Pacific, and other regions, enabling it to serve diverse markets and customer bases globally.
The company's portfolio includes several well-established brands and product lines developed through organic growth and strategic acquisitions. Notable brands within the orthopedics segment include DJO, a leading provider of orthopedic devices and solutions, and EMPI, which specializes in rehabilitation equipment. The rehabilitation segment includes products and services focused on physical therapy, sports medicine, and patient recovery applications.
Enovis operates manufacturing facilities, distribution centers, and research and development operations across multiple countries to support its global customer base. The company employs thousands of professionals worldwide dedicated to product innovation, manufacturing, quality assurance, and customer service.
The business model centers on providing evidence-based solutions that improve patient mobility, reduce pain, and accelerate recovery across orthopedic and rehabilitation care settings. Enovis maintains competitive advantages through its diversified product portfolio, established brand recognition, extensive distribution networks, and commitment to clinical research and product innovation. The company's integrated approach to orthopedic and rehabilitation care positions it to address comprehensive patient needs throughout the recovery journey.
Company details
- Sector
- Healthcare
- Industry
- Medical Instruments
- Headquarters
- LEWISVILLE, TX
- Fiscal year end
- December
- CIK
- 1420800
- SIC
- 3842
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Enovis CORP — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Enovis CORP’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Enovis CORP’s bonds, as funds hold them
Funds report holding 1 issues of Enovis CORP’s debt, $32.50M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 3.88%, maturing 2028 to 2028.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Enovis CORP and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Enovis CORP's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Enovis CORP's last four quarterly filings that the numbers alone won't show?”